BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND SSX2, HD21, 6757, ENSG00000157950, SSX, HOM-MEL-40, MGC3884, MGC15364, MGC119055, RP11-552J9_2
37769 results:

  • 1. Hybrid chain reaction and selective recognition-based homogeneous dual-fluorescence analysis of circulating tumor cells in clinical ovarian cancer samples.
    Hu Q; Tang D; Li M; Liang X; Zhou J; Meng Y; Wei Y; Yan S; Lin R; Niu X; Zhang L
    Anal Chim Acta; 2023 Nov; 1281():341877. PubMed ID: 38783734
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A synthetic lethal dependency on casein kinase 2 in response to replication-perturbing therapeutics in RB1-deficient cancer cells.
    Bulanova D; Akimov Y; Senkowski W; Oikkonen J; Gall-Mas L; Timonen S; Elmadani M; Hynninen J; Hautaniemi S; Aittokallio T; Wennerberg K
    Sci Adv; 2024 May; 10(21):eadj1564. PubMed ID: 38781347
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics.
    Sun J; Feng Q; Xu Y; Liu P; Wu Y
    J Ovarian Res; 2024 May; 17(1):110. PubMed ID: 38778371
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CA-125 elimination rate constant K (KELIM) as a promising predictor of complete cytoreduction after neoadjuvant chemotherapy in advanced ovarian cancer patients: a retrospective study from two Chinese hospitals.
    Li C; Cui Q; Wang X; Yao S; Tu H; Chen M
    BMC Cancer; 2024 May; 24(1):609. PubMed ID: 38769484
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Racial and Ethnic Inequities in cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
    Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
    JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
    Liu Y; Shi W; Mubarik S; Wang F
    BMC Public Health; 2024 May; 24(1):1349. PubMed ID: 38764017
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Fu M; Deng F; Chen J; Fu L; Lei J; Xu T; Chen Y; Zhou J; Gao Q; Ding H
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757340
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
    Li H; Peng Z; Zhu J; Zhao W; Huang Y; An R; Zheng H; Qu P; Wang L; Zhou Q; Wang D; Lou G; Wang J; Wang K; Kong B; Xie X; Yin R; Low J; Rozita AM; Sen LC; Meng YC; Kiong KS; Liu J; Liang Z; Lv W; Zhu Y; Hu W; Sun W; Su J; Wang Q; Zang R; Ma D; Gao Q
    BMC Med; 2024 May; 22(1):199. PubMed ID: 38755585
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. When to reinvite initially ineligible populations for targeted lung cancer screening?
    Goodley P; Crosbie PAJ; Sperrin M; Merchant Z; Booton R; Balata H
    BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38754907
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
    Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
    JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study.
    Schlootz S; Saner FAM; Rabaglio M; Imboden S; Wampfler J
    Swiss Med Wkly; 2024 Apr; 154():3386. PubMed ID: 38754016
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in cancer: A Systematic Review and Meta-Analysis.
    Gao L; Fan J; He J; Che X; Wang X; Han C
    Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
    Chung DC; Ghaedi M; Warner K; Sayad A; Saibil SD; Bernardini MQ; Clarke BA; Shaw PA; Butler MO; Easson A; Morrissy S; Wang BX; Nguyen L; Ohashi PS; Jacquelot N
    Oncoimmunology; 2024; 13(1):2349347. PubMed ID: 38746870
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Blood Lead Level as Marker of Increased Risk of ovarian cancer in BRCA1 Carriers.
    Kiljańczyk A; Matuszczak M; Marciniak W; Derkacz R; Stempa K; Baszuk P; Bryśkiewicz M; Lubiński K; Cybulski C; Dębniak T; Gronwald J; Huzarski T; Lener MR; Jakubowska A; Szwiec M; Stawicka-Niełacna M; Godlewski D; Prusaczyk A; Jasiewicz A; Kluz T; Tomiczek-Szwiec J; Kilar-Kobierzycka E; Siołek M; Wiśniowski R; Posmyk R; Jarkiewicz-Tretyn J; Sun P; Scott RJ; Narod SA; Lubiński J
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732616
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Role of Glutathione Transferase Omega-Class Variant Alleles in Individual Susceptibility to ovarian cancer.
    Simic P; Coric V; Pljesa I; Savic-Radojevic A; Zecevic N; Kocic J; Simic T; Pazin V; Pljesa-Ercegovac M
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732205
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
    Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.
    Zhao J; Wang D; Wang R; He Y; Jia C; Pan L; Ma S; Wu M; Wang W; Cheng X; Yang J; Xiang Y
    J Ovarian Res; 2024 May; 17(1):96. PubMed ID: 38720349
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk of Subsequent Primary cancers Among Adult-Onset 5-Year cancer Survivors in South Korea: Retrospective Cohort Study.
    Choi YY; Lee M; Kim EH; Lee JE; Jung I; Cheong JH
    JMIR Public Health Surveill; 2024 May; 10():e48380. PubMed ID: 38717807
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1889.